These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7626321)

  • 21. Effects of two novel bisphosphonates on bone cells in vitro.
    Evans CE; Braidman IP
    Bone Miner; 1994 Aug; 26(2):95-107. PubMed ID: 7994190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone morphogenetic protein 2 stimulates osteogenesis but does not affect chondrogenesis in osteochondrogenic differentiation of periosteum-derived cells.
    Iwasaki M; Nakahara H; Nakase T; Kimura T; Takaoka K; Caplan AI; Ono K
    J Bone Miner Res; 1994 Aug; 9(8):1195-204. PubMed ID: 7976502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts.
    Fromigué O; Body JJ
    J Endocrinol Invest; 2002 Jun; 25(6):539-46. PubMed ID: 12109626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dexamethasone stimulates osteogenesis in chick periosteum in vitro.
    Tenenbaum HC; Heersche JN
    Endocrinology; 1985 Nov; 117(5):2211-7. PubMed ID: 4042982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tamoxifen attenuates glucocorticoid actions on bone formation in vitro.
    Sukhu B; Rotenberg B; Binkert C; Kohno H; Zohar R; McCulloch CA; Tenenbaum HC
    Endocrinology; 1997 Aug; 138(8):3269-75. PubMed ID: 9231777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effects of disodium etidronate and pamidronate against the biomechanical repercussion of betamethasone-induced osteopenia in growing rat femurs.
    Ferretti JL; Delgado CJ; Capozza RF; Cointry G; Montuori E; Roldán E; Pérez Lloret A; Zanchetta JR
    Bone Miner; 1993 Mar; 20(3):265-76. PubMed ID: 8490330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix vesicle calcification of ectopically induced osteoid tissue in 1-hydroxethylidene-1,1-bisphosphonate (HEBP)-treated mice.
    Morris DC; Anderson HC; Yoshikawa H; Nakahara H; Takaoka K; Ono K
    Bone; 1990; 11(4):281-6. PubMed ID: 2122913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of 1-hydroxyethylidene-1, 1-bisphosphonate (HEBP) on the synthesis of dentin matrix proteins in the mouse.
    van den Bos T; Beertsen W
    Coll Relat Res; 1987 Jun; 7(2):135-47. PubMed ID: 3113818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo.
    Giuliani N; Pedrazzoni M; Negri G; Passeri G; Impicciatore M; Girasole G
    Bone; 1998 May; 22(5):455-61. PubMed ID: 9600778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apposition and resorption of bone during oral treatment with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).
    Reitsma PH; Bijvoet OL; Potokar M; van der Wee-Pals LJ; van Wijk-van Lennep MM
    Calcif Tissue Int; 1983 May; 35(3):357-61. PubMed ID: 6871766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of bone matrix apposition by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (AHPrBP) in the mouse.
    Marie PJ; Hott M; Garba MT
    Bone; 1985; 6(3):193-200. PubMed ID: 4027097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth inhibition of macrophage-like and other cell types by liposome-encapsulated, calcium-bound, and free bisphosphonates in vitro.
    Mönkkönen J; Taskinen M; Auriola SO; Urtti A
    J Drug Target; 1994; 2(4):299-308. PubMed ID: 7858955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.
    Carano A; Teitelbaum SL; Konsek JD; Schlesinger PH; Blair HC
    J Clin Invest; 1990 Feb; 85(2):456-61. PubMed ID: 2105340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of osteoblast function in vitro by aminobisphosphonates.
    Orriss IR; Key ML; Colston KW; Arnett TR
    J Cell Biochem; 2009 Jan; 106(1):109-18. PubMed ID: 19003973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisphosphonates and extrarenal acid buffering capacity.
    Freudiger H; Bonjour JP
    Calcif Tissue Int; 1989 Jan; 44(1):3-10. PubMed ID: 2521807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inorganic polyphosphate in human osteoblast-like cells.
    Leyhausen G; Lorenz B; Zhu H; Geurtsen W; Bohnensack R; Müller WE; Schröder HC
    J Bone Miner Res; 1998 May; 13(5):803-12. PubMed ID: 9610744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. beta-Glycerophosphate-induced mineralization of osteoid does not alter expression of extracellular matrix components in fetal rat calvarial cell cultures.
    Lee KL; Aubin JE; Heersche JN
    J Bone Miner Res; 1992 Oct; 7(10):1211-9. PubMed ID: 1456088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro.
    Idris AI; Rojas J; Greig IR; Van't Hof RJ; Ralston SH
    Calcif Tissue Int; 2008 Mar; 82(3):191-201. PubMed ID: 18259679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of the administration of bisphosphonates for the prevention of periosteal bone formation following Moloney sarcoma virus-induced tumors.
    Włodarski P; Włodarski K; Galus K; Luczak M
    Folia Biol (Praha); 1993; 39(6):297-303. PubMed ID: 7926159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells.
    Andrades JA; Han B; Becerra J; Sorgente N; Hall FL; Nimni ME
    Exp Cell Res; 1999 Aug; 250(2):485-98. PubMed ID: 10413602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.